Finally, the identification of single nucleotide polymorphism of IL-22 binding protein (IL-22BP, also called IL-2RA), an antagonist of IL-22, as an MS risk gene [138,139] supports a role of IL-22-producing cells in the immunopathogenesis of MS. The gene discussed is IL22RA2; the disease is myeloid sarcoma.